STING1 and neoplasm: Researchers initially investigated the relationship between STK11 expression and the tumor immune microenvironment and found that the loss of STK11 expression may result in a reduction in the infiltration of the tumor microenvironment by cytotoxic CD8+ T-cells, a decreasing in the expression of STING, and a decline in immune activity.